Activators, therapeutics and immunity-related aspects of thrombosis

References
1 Geddings JE, Mackman N. Recently Identified Factors that Regulate Hemostasis and Thrombosis.. Thromb Haemost 2014; 111: 570-574.
2 Langer F, Ruf W. Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation.. Thromb Haemost 2014; 111: 590-597.
3 Kannemeier C, Shibamiya A, Nakazawa F. et al. Extracellular RNA constitutes a natural procoagu-lant cofactor in blood coagulation.. Proc Natl Acad Sci USA 2007; 104: 6388-6393.
4 Massberg S, Grahl L, von Bruehl M-L. et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.. Nat Med 2010; 16: 887-896.
5 von Brühl ML, Stark K, Steinhart A. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.. J Exp Med 2012; 209: 819-835.
6 Smith SA, Mutch NJ, Baskar D. et al. Polyphosphate modulates blood coagulation and fibrinoly-sis.. Proc Natl Acad Sci USA 2006; 103: 903-908.
7 Müller F, Mutch NJ, Schenk WA. et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.. Cell 2009; 139: 1143-1156.
8 Essex DW. Redox control of platelet function.. Antioxid Redox Signal 2009; 11: 1191-1225.
9 Reinhardt C, von Brühl ML, Manukyan D. et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation.. J Clin Invest 2008; 118: 1110-1122.
10 Fuchs TA, Brill A, Duerschmied D. et al. Extracellular DNA traps promote thrombosis.. Proc Natl Acad Sci USA 2010; 107: 15880-15885.
11 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity.. Nat Rev Immunol 2013; 13: 34-45.
12 Huck V, Schneider M, Gorzelanny C. et al. The various states of von Willebrand factor and their functions in physiology and pathophysiology.. Thromb Haemost 2014; 111: 598-609.
13 Huntington JA. Natural inhibitors of thrombin.. Thromb Haemost 2014; 111: 583-589.
14 Schulman S. New oral anticoagulant agents - general features and outcomes in subsets of patients.. Thromb Haemost 2014; 111: 575-582.
15 Bock F, Shahzad K, Vergnolle N. et al. Activated protein C based therapeutic strategies in chronic diseases.. Thromb Haemost 2014; 111: 610-617.
16 Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects.. Blood 2009; 113: 2878-2887.